<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Richa Agrawal</style></author><author><style face="normal" font="default" size="100%">Rajesh Maheshwari</style></author><author><style face="normal" font="default" size="100%">Ramachandran Balaraman</style></author><author><style face="normal" font="default" size="100%">Avinash Seth</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Anti-hyperglycemic and Anti-lipidemic activities of Diabac (a polyherbal formulation) in Streptozotocin-nicotinamide induced type 2 diabetic rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabac</style></keyword><keyword><style  face="normal" font="default" size="100%">Glycated hemoglobin</style></keyword><keyword><style  face="normal" font="default" size="100%">Liver glycogen</style></keyword><keyword><style  face="normal" font="default" size="100%">Serum lipids</style></keyword><keyword><style  face="normal" font="default" size="100%">Streptozotocin.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">01/2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><pages><style face="normal" font="default" size="100%">283-288</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Aim:&lt;/strong&gt; The objective of the work was to investigate the antidiabetic activity of Diabac (a polyherbal formulation) in streptozotocin-nicotinamide induced type 2 diabetic rats. &lt;strong&gt;Methods: &lt;/strong&gt;Oral glucose tolerance test (OGTT) was performed to evaluate effect of Diabac on elevated glucose level. The type 2 diabetes was induced by overnight fasted rats by a single intraperitoneal (i.p.) injection of 65 mg/kg streptozotocin, 15 min. after the i.p. administration of 110 mg/kg nicotinamide. The diabetic rats were treated with Diabac (250, 500 and 1000 mg/kg, p.o.) or glibenclamide (5 mg/kg, p.o) for four week. Various parameters were studied such as fasting blood sugar level, serum insulin levels, glycated hemoglobin (HbA&lt;sub&gt;1C&lt;/sub&gt;), serum lipid levels, se rum creatinine, urea, uric acid and liver glycogen. &lt;strong&gt;Results:&lt;/strong&gt; Treatment with Diabac significantly reduced the blood sugar levels in OGTT. Diabetic rats showed a significant increase in the levels of glycated hemoglobin, serum lipids, serum creatinine, urea and uric acid, whereas there was a decrease in serum insulin, liver glycogen and HDL-C levels as compared to normal control rats. The administration of Diabac or glibenclamide significantly decreased the levels of glycated hemoglobin, TG, TC, LDL-C, serum creatinine, urea and uric acid, whereas there was an increase in the levels of liver glycogen and HDL-C as compared to diabetic control rats. However, the treatment with Diabac did not show any significant change in serum insulin levels as compared to diabetic control rats. &lt;strong&gt;Conclusion: &lt;/strong&gt;These results of present study concluded that Diabac has anti-diabetic and anti-lipidemic activities which are responsible for its use in traditional medicine.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">283</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Richa Agrawal, Rajesh Maheshwari&lt;sup&gt;*&lt;/sup&gt;, Ramachandran Balaraman and Avinash Seth &lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;Department of Pharmacy, Sumandeep Vidyapeeth, Piparia, Vadodara, Gujarat, India.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rajesh Maheshwari</style></author><author><style face="normal" font="default" size="100%">Bhagyashree Pandya</style></author><author><style face="normal" font="default" size="100%">Ramachandran Balaraman</style></author><author><style face="normal" font="default" size="100%">Avinash Kumar Seth</style></author><author><style face="normal" font="default" size="100%">Yogesh Chand Yadav</style></author><author><style face="normal" font="default" size="100%">Vasa Siva Sankar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Hepatoprotective effect of Livplus-A polyherbal formulation</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">CCl4</style></keyword><keyword><style  face="normal" font="default" size="100%">GGT</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatic enzymes.</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatotoxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">Livplus</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">01/2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><pages><style face="normal" font="default" size="100%">311-316</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; The aim of the present study was to investigate the hepatoprotective effect of Livplus (a polyherbal formulation) against CCl&lt;sub&gt;4&lt;/sub&gt;-induced hepatotoxicity in rats. &lt;strong&gt;Methods:&lt;/strong&gt; Hepatotoxicity was induced in rats by i.p. injection of CCl&lt;sub&gt;4&lt;/sub&gt; once three days for 14 days. Livplus or Silymarin was administered along with CCl&lt;sub&gt;4&lt;/sub&gt; and the biochemical parameters like aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkalinephosphatase (ALP), total bilirubin (TB), direct bilirubin, total protein (TP), gamma-glutamyl transferase (GGT), total cholesterol (TC) and triglycerides (TG) were estimated. Furthermore, biomarkers of oxidative stress such as MDA levels, Glutathione contents, SOD and catalase activity in liver tissue were estimated. &lt;strong&gt;Results:&lt;/strong&gt; Treatment with Livplus significantly reduced the elevated levels of ALT, AST, ALP, bilirubin (direct and total), GGT, TC, TG and increased levels of TP compared to CCl&lt;sub&gt;4&lt;/sub&gt; control rats. The treatment with Livplus also showed a significant increase in glutathione contents, SOD and catalase activity and a decrease in MDA levels compared to CCl&lt;sub&gt;4&lt;/sub&gt; control rats. &lt;strong&gt;Conclusion:&lt;/strong&gt; The finding of present study indicates that Livplus showed a potential hepatoprotective activity. These results support the traditional use of Livplus in the treatment of liver disorders.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">311</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Rajesh Maheshwari&lt;sup&gt;*&lt;/sup&gt;, Bhagyashree Pandya, Ramachandran Balaraman, Avinash Kumar Seth, Yogesh Chand Yadav and Vasa Siva Sankar&lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;Department of Pharmacy, Sumandeep Vidyapeeth, Piparia, Vadodara, Gujarat, India.&lt;/p&gt;
</style></auth-address></record></records></xml>